A Machine‐Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma-Reference-Cited by-同舟云学术

A Machine‐Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma

Published:2019-12-19 Issue:4 Volume:107 Page:978-987
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wang Rui¹,Shao Xiao¹,Zheng Junying¹,Saci Abdel¹,Qian Xiaozhong¹,Pak Irene²,Roy Amit³,Bello Akintunde³,Rizzo Jasmine I.⁴,Hosein Fareeda⁴,Moss Rebecca A.⁴,Wind‐Rotolo Megan¹,Feng Yan³

Affiliation:

1. Oncology Translational Medicine Bristol‐Myers Squibb Lawrenceville New Jersey USA

2. Information and Data Management Bristol‐Myers Squibb New Brunswick New Jersey USA

3. Clinical Pharmacology and Pharmacometrics Bristol‐Myers Squibb Lawrenceville New Jersey USA

4. Global Clinical Research Bristol‐Myers Squibb Lawrenceville New Jersey USA

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1724

Reference45 articles.

1. Diagnostic and prognostic biomarkers in melanoma;Weinstein D.;J. Clin. Aesthet. Dermatol.,2014

2. Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

3. Immune system and melanoma biology: a balance between immunosurveillance and immune escape

4. Targeting T Cell Co-receptors for Cancer Therapy

5. The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare;Pharmaceutics;2024-02-27

2. Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors;Clinical Cancer Research;2023-12-13

3. Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology;Clinical Pharmacology & Therapeutics;2023-11-13

4. Time-Dependent Pharmacokinetics of Immune Checkpoint Inhibitors and their Implications and Considerations for Exposure–Response Analysis;Current Pharmacology Reports;2023-11-03

5. Quantitative Systems Pharmacology and Machine Learning: A Match Made in Heaven or Hell?;Journal of Pharmacology and Experimental Therapeutics;2023-08-31